Forschungsprojekte
Ergebnisse pro Seite:
10
2022 - 2025
Molecular T cell immunotherapy and inhibition of tumour immune escape mechanisms (Teilprojekt TP06 des SFB 1292, zweite Förderperiode)- Prof. Dr. Markus Munder,
- Univ.-Prof. Dr. Matthias Theobald
2021 - 2026
A Phase 3 Open-Label, Randomized Study of LOXO-305 versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN-MCL-321) (#1349)- Prof. Dr. med. Georg Heß,
- Marie-Kristin Tilch